RUA Life Sciences PLC

AOHA

Company Profile

  • Business description

    RUA Life Sciences PLC is engaged in contract design and manufacture of medical devices and exploiting the value of its IP and know-how, and developing of cardiovascular devices. Its segments include Biomaterials includes Licensor of Elast-Eon polymers to the medical device industry; Medical Devices and Components engages End-to-end contract developer, manufacturer, and seller of medical devices and implantable fabric specialist; Vascular engages in the development and commercialization of the group’s Elast-Eon sealed Vascular Graft products; and Structural Heart engages in the development of the group’s Elast-Eon composite heart valve material AurTex. Geographically it operates in Europe, North America, Middle East , Asia Pacific, and Africa.

  • Contact

    2 Drummond Crescent
    Ayrshire
    Scotland
    IrvineKA11 5AN
    GBR

    T: +44 1294317073

    E: [email protected]

    https://www.rualifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2026

    Employees

    40

Stocks News & Analysis

stocks

Market underestimating cheap ASX share

Investors missing the big opportunity in batteries.
stocks

As Nvidia crosses $5 trillion, 5 charts on the unstoppable tech rally

Demand for AI has catapulted tech stocks into the stratosphere.
stocks

Westpac earnings: Tech overhaul is costly but not hurting lending and deposit growth

Our view after latest earnings report.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,098.2075.80-0.83%
CAC 408,067.5342.26-0.52%
DAX 4023,949.11183.30-0.76%
Dow JONES (US)47,035.45301.23-0.64%
FTSE 1009,714.9613.590.14%
HKSE25,952.40205.96-0.79%
NASDAQ23,378.15456.57-1.92%
Nikkei 22551,497.20914.14-1.74%
NZX 50 Index13,605.9649.660.37%
S&P 5006,772.7279.25-1.16%
S&P/ASX 2008,813.7069.00-0.78%
SSE Composite Index3,960.1916.33-0.41%

Market Movers